Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 11—November 2011

CME ACTIVITY

Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007

James R. JohnsonComments to Author , Megan E. Menard, Tsai-Ling Lauderdale, Chris Kosmidis, David Gordon, Peter Collignon, Joel N. Maslow, Arjana Tambić Andrašević, and Michael A. Kuskowski
Author affiliations: Veterans Affairs Medical Center, Minneapolis, Minnesota, USA (J.R. Johnson, M.E. Menard, M.A. Kuskowski); University of Minnesota, Minneapolis (J.R. Johnson, M.A. Kuskowski); National Health Research Institutes, Zhunan, Taiwan (T.-L. Lauderdale); University of Athens Medical School, Athens, Greece (C. Kosmidis); Australian National University, Canberra, Australian Capital Territory, Australia (D. Gordon, P. Collignon); Canberra Hospital, Canberra (P. Collignon); Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA (J.N. Maslow); University of Pennsylvania, Philadelphia (J.N. Maslow); University Hospital for Infectious Diseases, Zagreb, Croatia (A. Tambić Andrašević)

Main Article

Table 1

Origin and epidemiologic background of 2,210 extraintestinal Escherichia coli isolates from 32 globally distributed centers and susceptibility to trimethoprim/sulfamethoxazole, 1998–2007*

Continent, location†

Year(s) of isolation

Total no. isolates

S, %

Source, no. isolates

No. CGA isolates/total no. (%)

Specimen type

Setting

Child‡

Urine

Nonurine

In

Out

R

S

Africa

    Ile-Ife, Nigeria

2004

41

NK

41

0

22

19

4

3/36 (8)

0/5 (0)

    Lusaka, Zambia

2001

51

59

4

37

NK

NK

0

0/31 (0)

0/20 (0)

Asia

    Chandigarh, India

2006

50

60

37

13

34

16

9

0/36 (0)

0/14 (0)

    Kitakyushu, Japan

2001–2005

56

80

37

19

36

20

7

1/29 (3)

0/27 (0)

    Singapore

2002

50

60

43

7

NK

NK

0

1/25 (4)

0/25 (0)

    Taiwan

1998–2004

320

46

256

64

66

254

73

8/161 (5)

8/159 (5)

Australia/New Zealand

    Canberra, Australia

1998–2001

121

80

50

71

0

121

5

10/60 (17)

3/61 (5)

    Palmerston North, New     Zealand

2006

51

78

36

15

18

33

3

1/24 (4)

0/27 (0)

Europe

    Zagreb, Croatia

2001–2002

91

81

44

47

58

33

0

8/46 (17)

1/45 (2)

    Athens, Greece

2003–2005

149

66

96

53

92

57

3

15/75 (20)

1/74 (1)

    Varese, Italy

2006

51

75

35

16

31

20

3

0/26 (0)

0/25 (0)

    Santander, Spain

2003

53

70

35

18

19

34

9

0/26 (0)

2/27 (7)

    Bellinzona, Switzerland

2006

54

75

36

18

34

20

2

3/27 (11)

0/27 (0)

North America

    Calgary, Alberta, Canada

2001

54

78

36

18

34

20

10

6/27 (22)

1/27 (4)

    United States

        Denver, CO

2001

100

78

50

50

50

50

0

17/50 (34)

3/50 (6)

        West Haven, CT

2006

34

76

24

10

17

17

0

0/16 (0)

0/18 (0)

        Chicago, Il

2001

60

74

40

20

37

23

0

0/30 (0)

0/30 (0)

        Lexington, KY

2001

60

80

40

20

7

53

5

3/30 (10)

1/30 (3)

        Petoskey, MI

2001

45

89

NK.

NK

NK

NK

0

5/21 (24)

0/24 (0)

        Duluth, MN

2001

50

90

39

11

8

42

0

4/26 (15)

0/24 (0)

        Minneapolis, MN†

2001

66

87

56

10

15

51

0

1/26 (4)

1/40 (3)

        Minneapolis, MN†

2001

46

90

38

8

21

25

0

0/18 (0)

0/28 (0)

        Northfield, MN

2001

24

95

24

0

0

24

0

1/12 (8)

0/12 (0)

        St. Louis Park, MN

2001

64

83

64

0

0

64

7

9/32 (28)

3/32 (9)

        Fargo, ND

2001

54

90

49

5

5

49

11

1/27 (4)

1/27 (4)

        Philadelphia, PA

2006

94

78

87

7

13

81

0

2/22 (9)

0/72 (0)

        Houston, TX

2001

60

65

40

20

35

25

9

1/30 (3)

1/30 (3)

        Salt Lake City, UT

2001

47

85

31

16

24

23

4

1/21 (5)

1/26 (4)

South/Central America

    Concepción, Chile

2006

51

57

36

15

33

18

NK

5/24 (21)

1/27 (4)

    Cali, Columbia

2005–2006

51

52

36

15

27

24

16

3/24 (13)

1/27 (4)

    Panama City, Panama

2007

54

36

36

18

19

35

52

1/27 (4)

1/27 (4)

    Lima, Peru

2002–2006

58

82

39

19

30

28

18

4/58 (7)

Not done

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

Main Article

1Investigators who contributed data are listed at the end of this article.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO